RNS Number:0265K
Keryx Biopharmaceuticals Inc
14 April 2003

Keryx Biopharmaceuticals, Inc ("the Company")


Purchase of own shares for cancellation


The Company purchased on the open market 2,400 shares of its common stock for
cancellation at a price of $1.25 per share on 11 April 2003.


14 April 2003


Contact:

Mr Bob Trachtenberg

General Counsel, Keryx Biopharmaceuticals, Inc.

Tel: 00 972 2541 3500




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

POSIIMFTMMJBBRJ